Home › Calculator › LYRA Dividend Calculator 2026
LYRA Dividend Calculator 2026
No dividendHealthcareLyra Therapeutics, Inc. · OTC
Price: $0.19 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
LYRA is not a dividend-focused stock
LYRA pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
LYRA Dividend Yield
Lyra Therapeutics, Inc. (LYRA) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When LYRA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Lyra Therapeutics, Inc. (LYRA) — Dividend Analysis 2026
Lyra Therapeutics, Inc. operates as a clinical-stage biotechnology company, primarily focused on the creation and commercialization of anti-inflammatory treatments for individuals suffering from chronic rhinosinusitis (CRS). The company's unique technological approach allows for the direct delivery of therapeutic agents to the targeted tissue, ensuring prolonged efficacy from a singular dose. Its pipeline features several promising candidates, including LYR-210, an anti-inflammatory implantable drug matrix currently in Phase III clinical trials for CRS. Additionally, LYR-220 is under development for CRS patients who have not responded to previous medical treatments and still require intervention for their symptoms. Lyra has forged a partnership with LianBio Inflammatory Limited to facilitate the development and market entry of LYR-210 throughout specific Asian regions, encompassing mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. Established in 2005, the company was initially known as 480 Biomedical, Inc. before adopting the name Lyra Therapeutics, Inc. in July 2018. Its corporate headquarters are located in Watertown, Massachusetts.
LYRA Dividend & DRIP — Frequently Asked Questions
Does LYRA pay a dividend?
No. Lyra Therapeutics, Inc. (LYRA) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of LYRA?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does LYRA have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. LYRA has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to LYRA
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full LYRA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open LYRA position with:
🌍 LYRA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold LYRA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 LYRA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 LYRA Dividend Payment Schedule
LYRA pays quarterly — 4 times per year. Ex-div: —.
📊 LYRA vs Healthcare Benchmarks
How LYRA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LYRA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ LYRA Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| D-Return | 2026-05-14 | 640 | — | — | ||
| D-Return | 2026-04-01 | 2,000 | — | — | ||
| D-Return | 2026-04-01 | 667 | — | — | ||
| Sale | 2026-01-06 | 769 | $3.36 | $2.6K | ||
| Sale | 2026-01-06 | 1,702 | $3.36 | $5.7K | ||
| Sale | 2025-11-11 | 4,783 | $4.31 | $20.6K | ||
| Sale | 2025-11-12 | 7,862 | $4.06 | $31.9K | ||
| Sale | 2025-11-13 | 28,597 | $3.90 | $111.5K | ||
| Sale | 2025-11-11 | 537 | $4.31 | $2.3K | ||
| Sale | 2025-11-12 | 883 | $4.06 | $3.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare LYRA with peers: LYRA vs BOLT · LYRA vs CHRS · LYRA vs ORIC
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LYRA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Lyra Therapeutics, Inc. (LYRA) is currently trading at $0.19, 97% below its 52-week high. It does not currently pay a regular dividend.
Does LYRA Pay a Dividend? Lyra Therapeutics, Inc. Dividend Status
Lyra Therapeutics, Inc. (LYRA) is a healthcare stock trading at $0.19. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest LYRA News
LiveProjected your LYRA DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.